Rare diseases
Investigational molecules
Locations
Back to Germany124 clinical trials in Kassel, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
GermanyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
GermanyA study testing duvakitug for patients with moderately to severely active ulcerative colitis
GermanyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
GermanyGermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
GermanyPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
GermanyPhase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on lung cancer treatments, including innovative therapies for both small-cell and non-small-cell variants. Multiple trials exploring new approaches for breast cancer treatment, particularly in early-stage and triple-negative cases.
Several studies investigating combination therapies and immunological approaches for better treatment outcomes.
Critical research examining heart failure prevention and management, with particular focus on novel drug combinations and cardiovascular risk reduction strategies.
Innovative approaches to reducing major cardiovascular events and improving patient outcomes.
Comprehensive studies on blood disorders and related conditions, including groundbreaking research in leukemia treatment protocols for children and adolescents.
Advanced therapeutic approaches combining traditional treatments with novel immunotherapy options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
